Debt-to-Equity Ratio
Updated 102h ago
Sector Performance
15th percentileCME
0.13x
Sector Median
0.73x
Sector Avg
0.08x
Deep Analysis
The debt-to-equity ratio compares a company’s total debt to its shareholders’ equity, showing how much it relies on borrowing versus its own funds.
CME’s current ratio of 0.13x means it uses very little debt relative to equity, indicating a conservative capital structure. This is well below the sector median of 0.73x, placing the company in the 15th percentile among peers, meaning it has less leverage than 85% of the sector. The year-over-year change and quarter-over-quarter change are both listed as N/A, so no trend data is available to assess recent shifts in leverage. The combination of a very low debt level with no trend information implies minimal financial risk from debt but leaves uncertainty about whether the company is actively reducing or increasing leverage. This metric supports the overall NEUTRAL verdict because the low ratio suggests stability, yet the absence of trend data prevents a stronger bullish or bearish bias.
Frequently Asked Questions
What does the Debt-to-Equity Ratio tell investors about CME?
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
How is the Debt-to-Equity Ratio calculated?
Debt-to-Equity Ratio is calculated as: Total Debt / Shareholders' Equity.
Who are CME's closest peers by Debt-to-Equity Ratio?
The closest peers by Debt-to-Equity Ratio include: ETSY (-2.62x), MCK (-3.00x), TDG (-3.40x), VRSK (-3.81x), MAR (-4.04x).
The Formula
Total Debt / Shareholders' Equity
Why It Matters
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
Master CME's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full CME research report →CME
0.13x
Sector Median
0.73x
Sector Avg
0.08x
How CME's Debt-to-Equity Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.